Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
The Journal of Infectious Diseases|April 14, 2000
Effects of Mycobacterium avium complex-infection treatment on cytokine expression in human immunodeficiency virus-infected persons: results of AIDS clinical trials group protocol 853R D MacArthur, M M Lederman, C A Benson, et al.
The Journal of Infectious Diseases|September 1, 1994
Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNAH J Lin, L E Myers, B Yen-Lieberman, et al.
Cancer Research|February 1, 1991
Phase I trial of natural human interferon beta in metastatic malignancyR M Bukowski, J S Sergi, W J Sharfman, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1994
Combination therapy with a synthetic peptide of C-reactive protein and interleukin 2: augmented survival and eradication of pulmonary metastasesB P Barna, M J Thomassen, M Maier, et al.
Journal of Breath Research|July 16, 2011
Effect of the influenza A (H1N1) live attenuated intranasal vaccine on nitric oxide (FE(NO)) and other volatiles in exhaled breathA Mashir, K M Paschke, D van Duin, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 26, 2013
KIR and HLA interactions are associated with control of primary CMV infection in solid organ transplant recipientsD van Duin, R K Avery, S Hemachandra, et al.
Journal of Acquired Immune Deficiency Syndromes|April 1, 1994
A phase I/II trial of intravenous L-2-oxothiazolidine-4-carboxylic acid (procysteine) in asymptomatic HIV-infected subjectsR C Kalayjian, G Skowron, R T Emgushov, et al.
Hepatology (Baltimore, Md.)|October 26, 1999
Outcome of de novo hepatitis C virus infection in heart transplant recipientsJ P Ong, D S Barnes, Z M Younossi, et al.
Journal of Clinical Microbiology|May 5, 2006
Multilaboratory comparison of hepatitis C virus viral load assaysA M Caliendo, A Valsamakis, Y Zhou, et al.
Journal of Clinical Microbiology|November 1, 1996
Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratoriesB Yen-Lieberman, D Brambilla, B Jackson, et al.
Pageof 6